On the other hand, Aso et al., Beckett et al. and Brownlow et al. failed to report any significant improvement in brain amyloid load after KD in APP/PS1 [17, 18], APP+PS1 and Tg4510 (tau) AD mouse models [19]. This evidence concerns the gene MAPT and Alzheimer disease.